Chemical activators of GLIPR1L1 can initiate a cascade of intracellular events leading to the protein's activation. Phorbol 12-myristate 13-acetate (PMA) directly activates Protein Kinase C (PKC), a pivotal kinase in cellular signaling that can phosphorylate GLIPR1L1. The phosphorylation state of GLIPR1L1 is essential for its activity, and thus, PMA can enhance its function through PKC's action. Forskolin, by increasing intracellular cAMP, indirectly stimulates Protein Kinase A (PKA), which can also phosphorylate GLIPR1L1 or its associated proteins, leading to functional activation. Similarly, Ionomycin, by elevating intracellular calcium levels, can activate calcium-sensitive kinases, potentially resulting in GLIPR1L1 phosphorylation and activation. Okadaic Acid contributes to this phosphorylated state by inhibiting protein phosphatases PP1 and PP2A, preventing GLIPR1L1 dephosphorylation and thus maintaining its active form.
In another vein, Anisomycin acts by activating stress-activated protein kinases, which can target GLIPR1L1 for phosphorylation. This signal amplification can ensure GLIPR1L1 remains active under cellular stress conditions. LY294002, as a PI3K inhibitor, can indirectly cause the activation of other kinases that compensate for PI3K inhibition and can phosphorylate GLIPR1L1. Rapamycin's inhibition of mTOR can similarly lead to the activation of kinases that act upstream, including those that can phosphorylate and activate GLIPR1L1. Further, 6-Benzylaminopurine can activate cyclin-dependent kinases, providing another phosphorylation route for GLIPR1L1 activation. Thapsigargin, by disrupting calcium homeostasis, indirectly activates kinases that may phosphorylate GLIPR1L1. Phosphatidic Acid can activate mTOR, which is a critical part of signaling pathways that may phosphorylate and thereby activate GLIPR1L1. Dibutyryl-cAMP, a cAMP analogue, activates PKA, which can then phosphorylate GLIPR1L1. Lastly, Calyculin A inhibits phosphatases PP1 and PP2A, leading to sustained phosphorylation and activation of GLIPR1L1 by preventing its dephosphorylation. Through these diverse mechanisms, these chemicals ensure that GLIPR1L1 is phosphorylated and remains in an active state, ready to carry out its cellular functions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC) which is involved in signaling pathways that can lead to the activation of GLIPR1L1 by phosphorylation. PKC-mediated phosphorylation of proteins is a common mechanism for enhancing the activity of many signaling proteins. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, elevating intracellular calcium levels. Elevated calcium may activate calcium-sensitive kinases which can phosphorylate GLIPR1L1, leading to its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A. This inhibition can prevent the dephosphorylation of GLIPR1L1, maintaining it in an active state through continued phosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases which can lead to the phosphorylation and subsequent activation of GLIPR1L1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor which may lead to the activation of compensatory pathways that include kinases which can phosphorylate and activate GLIPR1L1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can lead to the activation of upstream kinases that may phosphorylate GLIPR1L1, resulting in its activation. | ||||||
6-Benzylaminopurine | 1214-39-7 | sc-202428 sc-202428A | 1 g 5 g | $20.00 $52.00 | ||
6-Benzylaminopurine activates cyclin-dependent kinases that could phosphorylate GLIPR1L1, leading to its activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis, potentially activating kinases that can phosphorylate GLIPR1L1 and thereby activate it. | ||||||
Phosphatidic Acid, Dipalmitoyl | 169051-60-9 | sc-201057 sc-201057B sc-201057A | 100 mg 250 mg 500 mg | $106.00 $244.00 $417.00 | ||
Phosphatidic Acid can activate mTOR, which is part of signaling pathways that can lead to the phosphorylation and activation of GLIPR1L1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analogue which can activate PKA, and subsequently, PKA could phosphorylate and activate GLIPR1L1. | ||||||